PMID: 6405916May 21, 1983Paper

Should homosexuals be vaccinated against hepatitis B virus? Cost and benefit assessment

British Medical Journal
M W AdlerA Mindel

Abstract

The recent introduction of a vaccine against hepatitis B has raised the questions of who should be offered it and what the cost would be of a vaccination programme. An analysis was performed of the financial costs and benefits of such a programme designed to prevent acute hepatitis B in male homosexuals in the United Kingdom. Under various assumptions the total costs of screening and vaccination ranged from 2.2m pounds to 3m pounds for a five year programme and from 3.3m pounds to 4.8m pounds for a 10 year programme. The benefits over the same two periods for the programme, depending on two different assumptions of mortality prevented, ranged 3.9m pounds to 13.7m pounds and from 7m pounds to 24.4m pounds. Thus considerable savings may be made to the national economy by offering vaccination to homosexuals. These savings are obtained after consideration of only the acute aspects of hepatitis B. Had it been possible to determine the costs of the chronic sequelae of this disease the savings, compared with the costs, would have been greatly increased.

References

Aug 26, 1978·Lancet·I Jakobsson, T Lindberg
Jul 1, 1978·The Quarterly Journal of Medicine·J S StewartA J Zuckerman
Jan 1, 1975·Przegla̧d epidemiologiczny·A Kulesza
Oct 1, 1975·Annals of Internal Medicine·W SzmunessG H Block
Jun 30, 1973·Lancet·J Heathcote, S Sherlock
May 26, 1973·British Medical Journal·D J JeffriesR R Willcox
Jun 20, 1981·Lancet·R W EvansB Taylor
Nov 13, 1982·Lancet·A M Langer, W T McCaughey
Feb 1, 1983·British Journal of Industrial Medicine·G Berry, M L Newhouse
Sep 9, 1982·The New England Journal of Medicine·A G MulleyJ L Dienstag
Sep 9, 1982·The New England Journal of Medicine·J Chin
Oct 1, 1981·The British Journal of Venereal Diseases·E M Belsey, M W Adler
Feb 1, 1981·Seminars in Liver Disease·J H Hoofnagle
Aug 1, 1982·British Journal of Industrial Medicine·H F ThomasP M Sweetnam
Jul 1, 1982·Archives of Disease in Childhood·D W Hide, B M Guyer
Feb 20, 1981·JAMA : the Journal of the American Medical Association·W M Liebman
Dec 1, 1981·Australian Paediatric Journal·D B Thomas

❮ Previous
Next ❯

Citations

Mar 6, 1999·Vaccine·R T Mahoney, J E Maynard
Apr 17, 2001·Journal of Chromatography. B, Biomedical Sciences and Applications·J SanchezX Santarelli
Apr 25, 2001·Journal of Chromatography. B, Biomedical Sciences and Applications·V Fitton, X Santarelli
May 28, 2003·Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences·A M NoubhaniX Santarelli
Jul 31, 2003·Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences·Yung-Chuan LiuShing-Yi Suen
Jan 24, 1987·British Medical Journal·R G Finch
Jul 13, 1991·BMJ : British Medical Journal·N BhattiI V Weller
Jun 1, 1985·Archives of Emergency Medicine·A D Redmond
Jun 1, 1995·Journal of Epidemiology and Community Health·P MangtaniC E Normand
Apr 1, 1992·Genitourinary Medicine·R J Gilson
Mar 1, 1984·Controlled Clinical Trials·B S Hawkins
Jun 1, 1985·European Journal of Epidemiology·G PapaevangelouA Tassiopoulou
Jan 1, 1993·Scandinavian Journal of Infectious Diseases·J Struve, J Giesecke
Jan 1, 1994·Health Economics·T Jefferson, V Demicheli
Sep 5, 1989·Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences·A M Johnson, O N Gill
Jan 1, 1994·Journal of Medical Screening·J A Cairns, P Shackley

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.